Patents by Inventor Valentina Fonsato

Valentina Fonsato has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MICROVESICLES (MVS) DERIVED FROM ADULT STEM CELLS FOR USE IN THE THERAPEUTIC TREATMENT OF A TUMOR DISEASE
    Publication number: 20230248774
    Abstract: The invention is in the field of therapeutic treatment of tumours. The inventors have found that microvesicles derived from adult stem cells exert a remarkable anti-tumour effect when administered to a patient affected by a tumour disease. Preferred microvesicles are derived from a bone marrow-mesenchymal stem cell, a glomerular mesenchymal stem cell or a non-oval liver stem cell.
    Type: Application
    Filed: April 17, 2023
    Publication date: August 10, 2023
    Applicant: Fresenius Medical Care Deutschland GmbH
    Inventors: Stefania BRUNO, Maria Beatriz HERRERA SANCHEZ, Valentina FONSATO, Giovanni CAMUSSI, Ciro TETTA
  • Conditioned medium of liver progenitor cells
    Patent number: 10456425
    Abstract: The invention is in the field of regenerative medicine. It has been found that the conditioned medium of non-oval pluripotent liver progenitor cells exerts a tissue regenerating effect. A preparation of the cell free conditioned medium is therefore useful in the treatment of injury and organ failure, preferably liver and/or injury or failure.
    Type: Grant
    Filed: June 11, 2009
    Date of Patent: October 29, 2019
    Assignee: FRESENIUS MEDICAL CARE DEUTSCHLAND GMBH
    Inventors: Maria Beatriz Herrera Sanchez, Valentina Fonsato, Ciro Tetta, Giovanni Camussi
  • Conditioned medium of liver progenitor cells
    Patent number: 10357519
    Abstract: The invention is in the field of regenerative medicine. It has been found that the conditioned medium of non-oval pluripotent liver progenitor cells exerts a tissue regenerating effect. A preparation of the cell free conditioned medium is therefore useful in the treatment of injury and organ failure, preferably liver and/or injury or failure.
    Type: Grant
    Filed: January 23, 2017
    Date of Patent: July 23, 2019
    Assignee: FRESENIUS MEDICAL CARE DEUTSCHLAND GMBH
    Inventors: Maria Beatriz Herrera Sanchez, Valentina Fonsato, Ciro Tetta, Giovanni Camussi
  • MICROVESICLES (MVS) DERIVED FROM ADULT STEM CELLS FOR USE IN THE THERAPEUTIC TREATMENT OF A TUMOR DISEASE
    Publication number: 20190060369
    Abstract: The invention is in the field of therapeutic treatment of tumours. The inventors have found that microvesicles derived from adult stem cells exert a remarkable anti-tumour effect when administered to a patient affected by a tumour disease. Preferred microvesicles are derived from a bone marrow-mesenchymal stem cell, a glomerular mesenchymal stem cell or a non-oval liver stem cell.
    Type: Application
    Filed: September 10, 2018
    Publication date: February 28, 2019
    Applicant: Fresenius Medical Care Deutschland GmbH
    Inventors: Stefania BRUNO, Maria Beatriz HERRERA SANCHEZ, Valentina FONSATO, Giovanni CAMUSSI, Ciro TETTA
  • Microvesicles (MVs) derived from adult stem cells for use in the therapeutic treatment of a tumor disease
    Patent number: 10105395
    Abstract: The invention is in the field of therapeutic treatment of tumors. The inventors have found that microvesicles derived from adult stem cells exert a remarkable anti-tumor effect when administered to a patient affected by a tumor disease. Preferred microvesicles are derived from a bone marrow-mesenchymal stem cell, a glomerular mesenchymal stem cell or a non-oval liver stem cell.
    Type: Grant
    Filed: June 12, 2017
    Date of Patent: October 23, 2018
    Assignee: FRESENIUS MEDICAL CARE DEUTSCHLAND GMBH
    Inventors: Stefania Bruno, Maria Beatriz Herrera Sanchez, Valentina Fonsato, Giovanni Camussi, Ciro Tetta
  • MICROVESICLES (MVS) DERIVED FROM ADULT STEM CELLS FOR USE IN THE THERAPEUTIC TREATMENT OF A TUMOR DISEASE
    Publication number: 20170348356
    Abstract: The invention is in the field of therapeutic treatment of tumors. The inventors have found that microvesicles derived from adult stem cells exert a remarkable anti-tumour effect when administered to a patient affected by a tumor disease. Preferred microvesicles are derived from a bone marrow-mesenchymal stem cell, a glomerular mesenchymal stem cell or a non-oval liver stem cell.
    Type: Application
    Filed: June 12, 2017
    Publication date: December 7, 2017
    Applicant: Fresenius Medical Care Deutschland GmbH
    Inventors: STEFANIA BRUNO, Maria Beatriz Herrera Sanchez, Valentina Fonsato, Giovanni Camussi, Ciro Tetta
  • Microvesicles (MVS) derived from adult stem cells for use in the therapeutic treatment of a tumor disease
    Patent number: 9717760
    Abstract: The invention is in the field of therapeutic treatment of tumors. The inventors have found that microvesicles derived from adult stem cells exert a remarkable anti-tumor effect when administered to a patient affected by a tumor disease. Preferred microvesicles are derived from a bone marrow-mesenchymal stem cell, a glomerular mesenchymal stem cell or a non-oval liver stem cell.
    Type: Grant
    Filed: February 28, 2011
    Date of Patent: August 1, 2017
    Assignee: FRESENIUS MEDICAL CARE DEUTSCHLAND GMBH
    Inventors: Stefania Bruno, Maria Beatriz Herrera Sanchez, Valentina Fonsato, Giovanni Camussi, Ciro Tetta
  • CONDITIONED MEDIUM OF LIVER PROGENITOR CELLS
    Publication number: 20170182100
    Abstract: The invention is in the field of regenerative medicine. It has been found that the conditioned medium of non-oval pluripotent liver progenitor cells exerts a tissue regenerating effect. A preparation of the cell free conditioned medium is therefore useful in the treatment of injury and organ failure, preferably liver and/or injury or failure.
    Type: Application
    Filed: January 23, 2017
    Publication date: June 29, 2017
    Inventors: Maria Beatriz HERRERA SANCHEZ, Valentina FONSATO, Ciro TETTA, Giovanni CAMUSSI
  • Adult stem cell derived conditioned medium and/or adult stem cells for use in the therapeutic treatment of a tumor disease
    Patent number: 9034335
    Abstract: The invention is in the field of therapeutic treatment of tumors. It has been found that the conditioned medium resulting from culturing an adult stem cell capable of differentiating into a plurality of differentiated cell types in a liquid cell culture medium and/or the adult stem cell from which the conditioned medium is obtainable, exert a remarkable anti-tumor effect. The adult stem cell derived conditioned medium preferred in this therapeutic application is a cell free conditioned medium derived from a human liver stem cell (HLSC).
    Type: Grant
    Filed: December 7, 2010
    Date of Patent: May 19, 2015
    Assignee: FRESENIUS MEDICAL CARE DEUTSCHLAND GMBH
    Inventors: Maria Beatriz Herrera Sanchez, Valentina Fonsato, Ciro Tetta, Giovanni Camussi
  • MICROVESICLES (MVS) DERIVED FROM ADULT STEM CELLS FOR USE IN THE THERAPEUTIC TREATMENT OF A TUMOR DISEASE
    Publication number: 20120321723
    Abstract: The invention is in the field of therapeutic treatment of tumours. The inventors have found that microvesicles derived from adult stem cells exert a remarkable anti-tumour effect when administered to a patient affected by a tumour disease. Preferred microvesicles are derived from a bone marrow-mesenchymal stem cell, a glomerular mesenchymal stem cell or a non-oval liver stem cell.
    Type: Application
    Filed: February 28, 2011
    Publication date: December 20, 2012
    Applicant: FRESENIUS MEDICAL CARE DEUTSCHLAND G.M.B.H.
    Inventors: Stefania Bruno, Maria Herrera Sanchez, Valentina Fonsato, Giovanni Camussi, Ciro Tetta
  • ADULT STEM CELL DERIVED CONDITIONED MEDIUM AND/OR ADULT STEM CELLS FOR USE IN THE THERAPEUTIC TREATMENT OF A TUMOR DISEASE
    Publication number: 20120251489
    Abstract: The invention is in the field of therapeutic treatment of tumours. It has been found that the conditioned medium resulting from culturing an adult stem cell capable of differentiating into a plurality of differentiated cell types in a liquid cell culture medium and/or the adult stem cell from which the conditioned medium is obtainable, exert a remarkable anti-tumour effect. The adult stem cell derived conditioned medium preferred in this therapeutic application is a cell free conditioned medium derived from a human liver stem cell (HLSC).
    Type: Application
    Filed: December 7, 2010
    Publication date: October 4, 2012
    Inventors: Maria Beatriz Herrera Sanchez, Valentina Fonsato, Ciro Tetta, Giovanni Camussi
  • CONDITIONED MEDIUM OF LIVER PROGENITOR CELLS
    Publication number: 20110129439
    Abstract: The invention is in the field of regenerative medicine. It has been found that the conditioned medium of non-oval pluripotent liver progenitor cells exerts a tissue regenerating effect. A preparation of the cell free conditioned medium is therefore useful in the treatment of injury and organ failure, preferably liver and/or injury or failure.
    Type: Application
    Filed: June 11, 2009
    Publication date: June 2, 2011
    Inventors: Maria Beatriz Herrera Sanchez, Valentina Fonsato, Tetta Ciro, Camussi Giovanni